363.59MMarket Cap-360P/E (TTM)
17.500High16.460Low65.44KVolume17.350Open17.360Pre Close1.12MTurnover0.68%Turnover RatioLossP/E (Static)21.39MShares41.87052wk High-3.58P/B164.49MFloat Cap11.66552wk Low--Dividend TTM9.68MShs Float728.003Historical High--Div YieldTTM5.99%Amplitude11.665Historical Low17.095Avg Price1Lot Size
Cartesian Therapeutics Stock Forum
Cartesian Therapeutics Gets FDA Rare Pediatric Disease Designation for Dermatomyositis Treatment
Dow Jones· just
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Murat Kalayoglu(19.9%),Seven One Eight Three Four Irrevocable Trust(17.1%), etc.
SEC announcement
13 mins ago
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals...
No comment yet